RAM
BCDA icon

Roumell Asset Management’s BioCardia BCDA Stock Holding History

Roumell Asset Management’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-35,766
Closed -$1.11M – 22
2022
Q1 		$1.11M Sell
35,766
-26,793
-43% -$796K 1.8% 18
2021
Q4 		$1.82M Hold
62,559
– – 2.43% 14
2021
Q3 		$2.95M Sell
62,559
-21,255
-25% -$1.04M 3.9% 9
2021
Q2 		$4.99M Hold
83,814
– – 5.83% 7
2021
Q1 		$5.46M Buy
83,814
+46,140
+122% +$2.88M 7.89% 6
2020
Q4 		$1.96M Buy
37,674
+15,474
+70% +$618K 3.07% 13
2020
Q3 		$756K Hold
22,200
– – 1.5% 12
2020
Q2 		$796K Buy
+22,200
New +$1.2M 1.92% 13

Other funds holding BCDA

CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Roumell Asset Management's BCDA Position: Q2 2022 in Review

Roumell Asset Management sold out of BioCardia (BCDA) in Q2 2022, closing a stake of 35,766 shares — an estimated $1.11M sold.

Roumell Asset Management first reported a position in BCDA in Q2 2020 and held it in 8 quarters. The position peaked at $5.46M in Q1 2021. 26 funds tracked by Wall St. Rank hold BCDA as of Q2 2022.

  • Roumell Asset Management reported no remaining BioCardia position as of Q2 2022 after selling out during the quarter.
  • Roumell Asset Management sold 35,766 BioCardia shares in Q2 2022, an estimated $1.11M.
  • Roumell Asset Management first reported a position in BioCardia in Q2 2020 and held it in 8 quarters.
  • Roumell Asset Management's BioCardia position peaked at $5.46M in Q1 2021.
  • 26 funds tracked by Wall St. Rank held BioCardia as of Q2 2022.

Based on Roumell Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.